| |
| |
|
| Insider
Information: |
Weinhoff Gregory M |
| Relationship: |
Chief Financial Officer |
| City: |
Stamford |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
265,111 |
|
|
Indirect Shares
|
129,943 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$1,378,695 |
|
|
| Total
Shares |
395,054 |
|
|
| Total
Value |
$1,378,695 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
Director |
|
0 |
2008-08-14 |
129,943 |
Premium* |
|
|
Centessa Pharmaceuticals Plc |
CNTA |
Chief Financial Officer |
2024-03-31 |
265,111 |
2021-06-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CNTA |
Centessa Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2024-03-31 |
4 |
D |
$11.30 |
$132,685 |
D/D |
(11,742) |
265,111 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2024-02-01 |
4 |
D |
$8.19 |
$94,136 |
D/D |
(11,494) |
276,853 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
31,250 |
288,347 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2023-12-31 |
4 |
D |
$7.96 |
$93,466 |
D/D |
(11,742) |
257,097 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2023-09-30 |
4 |
D |
$6.47 |
$75,971 |
D/D |
(11,742) |
268,839 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2023-06-30 |
4 |
D |
$5.90 |
$69,279 |
D/D |
(11,742) |
280,581 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
77,200 |
300,615 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2022-12-31 |
4 |
D |
$3.10 |
$16,439 |
D/D |
(5,303) |
234,697 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2022-10-03 |
4 |
S |
$3.95 |
$19,359 |
D/D |
(4,901) |
231,099 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2022-09-30 |
4 |
D |
$4.25 |
$47,949 |
D/D |
(11,282) |
228,718 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2022-09-30 |
4 |
S |
$4.07 |
$16,270 |
D/D |
(4,000) |
236,000 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
230,000 |
240,000 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Financial Officer |
• – – |
2021-06-02 |
4 |
B |
$20.00 |
$200,000 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2008-08-14 |
4 |
S |
$17.00 |
$850,000 |
I/I |
(50,000) |
129,943 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2007-06-05 |
4 |
A |
$0.00 |
$0 |
I/I |
1,975,223 |
2,108,555 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • • |
2007-05-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
133,333 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
